MAGELLAN LONGEVITY
HomeResearchStudy library › What is the association between iron status biomarkers and all-cause…
Study summary · General aging biology & healthspan

What is the association between iron status biomarkers and all-cause or cause-specific mortality, and does this association differ between people with and without diabetes mellitus?

In one paragraph

Ferritin / Iron-Status Test, studied in 29,166 adults (J Endocr Soc 2024, PMID 38623382) — during a median follow-up of 18.83 years, 9,378 deaths were observed, including 3,420 cardiovascular disease (CVD) deaths and 1,969 cancer deaths. Scope: 29,166 adults, and the abstract states no limitations.

Source: J Endocr Soc 2024, PMID 38623382 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium

J Endocr Soc · 2024 · PMID 38623382 · DOI 10.1210/jendso/bvae063

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Iron status is linked to mortality risk, with different associations observed in people with and without diabetes, suggesting personalized approaches to iron management.

The question

What is the association between iron status biomarkers and all-cause or cause-specific mortality, and does this association differ between people with and without diabetes mellitus?

What they tested

The study aimed to investigate associations between iron metabolic biomarkers and all-cause and cause-specific mortality risk in the general population, and to explore heterogeneities in these associations among populations with and without diabetes mellitus.

How they did it

The study included 29,166 adults from NHANES III and NHANES 1999-2010, with mortality data linked to the National Death Index up to December 31, 2019. Cox proportional-hazard models and Fine-Gray subdistribution hazard models were used to analyze the associations between iron metabolic biomarkers and mortality outcomes.

What they found

During a median follow-up of 18.83 years, 9,378 deaths were observed, including 3,420 cardiovascular disease (CVD) deaths and 1,969 cancer deaths. A linear association between serum ferritin (SF) and all-cause mortality was found in the overall population and those without diabetes. J-shaped associations between transferrin saturation (TSAT) and all-cause and CVD mortality were observed across all populations. In the overall population, the adjusted hazard ratio (HR) for all-cause mortality in the fourth quartile (Q4) of SF was 1.13 (1.05-1.21) compared to the first quartile (Q1), while for TSAT, the HR in Q4 was 0.93 (0.88-0.99). For individuals without diabetes, the adjusted HR of Q4 SF was 1.19 (1.03-1.37) for CVD mortality and 1.25 (1.05-1.48) for cancer mortality. In individuals with diabetes, the adjusted HRs of Q4 TSAT were 0.76 (0.62-0.93) for CVD mortality and 1.47 (1.07-2.03) for cancer mortality.

Adjusted Hazard Ratios for All-Cause Mortality by Quartile of Serum Ferritin and Transferrin Saturation (Overall Population)
Values shown: Adjusted Hazard Ratio
SF Q21.07
SF Q31.05
SF Q41.13
TSAT Q20.94
TSAT Q30.92
TSAT Q40.93

Compared to the first quartile (Q1), the adjusted hazard ratios for all-cause mortality show varying associations with higher quartiles of serum ferritin (SF) and transferrin saturation (TSAT) in the overall population.

What it means

Abnormalities in iron metabolism increase mortality risk in the general population. The associations between iron status and mortality differ significantly between individuals with and without diabetes mellitus, suggesting a need for tailored strategies for iron homeostasis.

Limitations

The abstract does not explicitly state limitations of the study.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“Iron metabolism abnormalities increase mortality risk in the general population”— from the published abstract, J Endocr Soc 2024

The paper at a glance

Magellan’s evidence labelSerum ferritin (iron stores) (our label for this citation — see PubMed for the paper’s own title and authors)
JournalJ Endocr Soc
Year2024
PMID38623382 ↗
DOI10.1210/jendso/bvae063 ↗
TopicGeneral aging biology & healthspan

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Ferritin / Iron-Status Test

Iron status has a U-shaped relationship with health: iron deficiency (low ferritin) is a leading cause of anemia and, even without anemia, is associated with fatigue that iron repletion can improve, while in older adults it has been linked to more severe infections;

Ferritin / Iron-Status Test

Ferritin is the body's main intracellular iron-storage protein, and the concentration of ferritin…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What is the association between iron status biomarkers and all-cause or cause-specific mortality, and does this association differ between people with and without diabetes mellitus? [Plain-English summary of J Endocr Soc 2024, PMID 38623382, DOI 10.1210/jendso/bvae063]. Magellan Longevity. https://magellanlongevity.com/study/s147.html
BibTeX
@misc{magellan_s147, title = {What is the association between iron status biomarkers and all-cause or cause-specific mortality, and does this association differ between people with and without diabetes mellitus?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/s147.html}}, note = {Plain-English summary of PubMed PMID 38623382; DOI 10.1210/jendso/bvae063; J Endocr Soc 2024. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/s147.html

Related studies in the Magellan library

All 25 Magellan summaries on general aging biology & healthspan →

How this summary was made. Every section above restates what the published abstract of PMID 38623382 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.